{"url_path":"/sec/armp/8-k/2026-06-23/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-23","source_url":"https://www.sec.gov/Archives/edgar/data/921114/0001104659-26-076627-index.html","accession_number":"0001104659-26-076627","cik":"0000921114","ticker":"ARMP","issuer_name":"Armata Pharmaceuticals, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/921114/0001104659-26-076627-index.html","primary_entity_key":"0000921114","primary_entity_name":"Armata Pharmaceuticals, Inc."},"word_count":90,"has_tables":true,"body_markdown":"**Item 9.01**\n**Financial Statements and Exhibits.**\n\n \n\n \n**(d)**\n**Exhibits.**\n\n \n\n**Exhibit\nNo.**\n \n**Description**\n\n[99.1](tm2618503d1_ex99-1.htm)\n \n[Press Release, dated June 23, 2026.](tm2618503d1_ex99-1.htm)\n\n104\n \nCover Page Interactive Data File (embedded within the Inline XBRL document\n\n \n\n \n\n- 2 -\n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities\nExchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\nDate: June 23, 2026\n**Armata Pharmaceuticals, Inc.**\n\n \n \n\n \nBy:\n/s/ David House\n\n \nName:\nDavid House\n\n \nTitle:\nSenior Vice President, Finance and Principal Financial Officer\n\n \n\n- 3 -"}